<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39604990</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1472-6947</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Nov</Month><Day>28</Day></PubDate></JournalIssue><Title>BMC medical informatics and decision making</Title><ISOAbbreviation>BMC Med Inform Decis Mak</ISOAbbreviation></Journal><ArticleTitle>How to establish and sustain a disease registry: insights from a qualitative study of six disease registries in the UK.</ArticleTitle><Pagination><StartPage>361</StartPage><MedlinePgn>361</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">361</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12911-024-02775-x</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The advent of new chronic conditions such as long COVID-19 raises the question of whether and, if so, how best to establish new disease registries for such conditions. Prompted by the potential need for a long COVID-19 registry, we examined experiences of existing UK disease registries to understand barriers and enablers to establishing and sustaining a register, and how these have changed over time.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We undertook semi-structured interviews between November 2022 and April 2023 with individuals representing six disease registries that collect individual-level longitudinal data on people diagnosed with a chronic condition.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Registries examined were developed by a few individuals, usually clinicians, to gain a greater understanding of the disease. Patient voices were largely absent from initial agenda setting processes, but, over time, all registries sought to increase patient involvement. Securing long-term funding was cited as the biggest challenge; due to limited funds, one of the registries examined no longer actively recruits patients. Charities devoted to the diseases in question were key funders, though most registries also sought commercial opportunities. Inclusion on the NIHR Clinical Research Network Portfolio was also considered a vital resource to support recruitment and follow-up of participants. All registries have sought to minimise the primary data collected to reduce the burden on clinicians and patients, increasingly relying on linkage to other data sources. Several registries have developed consent procedures that enable participants to be contacted for additional data collection. In some cases, the initial patient consent and data sharing permissions obtained had limited the flexibility to adapt the registry to changing data needs. Finally, there was a need to foster buy-in from the community of patients and clinicians who provide and/or use the data.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">We identified six key considerations when establishing a sustainable disease registry: (1) include a diverse set of stakeholders; (2) involve patients at every stage; (3) collect a core data set for all participants; (4) ensure the data system is flexible and interoperable with the wider data landscape; (5) anticipate changing data needs over time; and (6) identify financial opportunities to sustain the registry's activities for the long term.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Stubbs</LastName><ForeName>Edmund</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Policy Innovation and Evaluation Research Unit, Care Policy and Evaluation Centre, London School of Economics and Political Science, Houghton Street, London, WC2A 2AE, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Exley</LastName><ForeName>Josephine</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Health Services Research and Policy, Policy Innovation and Evaluation Research Unit, London School of Hygiene &amp; Tropical Medicine, 15-17 Tavistock Place, London, WC1H 9SH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wittenberg</LastName><ForeName>Raphael</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Policy Innovation and Evaluation Research Unit, Care Policy and Evaluation Centre, London School of Economics and Political Science, Houghton Street, London, WC2A 2AE, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mays</LastName><ForeName>Nicholas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Health Services Research and Policy, Policy Innovation and Evaluation Research Unit, London School of Hygiene &amp; Tropical Medicine, 15-17 Tavistock Place, London, WC1H 9SH, UK. Nicholas.Mays@lshtm.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>PR-PRU-1217-20602</GrantID><Agency>National Institute for Health and Care Research</Agency><Country/></Grant><Grant><GrantID>PR-PRU-1217-20602</GrantID><Agency>National Institute for Health and Care Research</Agency><Country/></Grant><Grant><GrantID>PR-PRU-1217-20602</GrantID><Agency>National Institute for Health and Care Research</Agency><Country/></Grant><Grant><GrantID>PR-PRU-1217-20602</GrantID><Agency>National Institute for Health and Care Research</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Med Inform Decis Mak</MedlineTA><NlmUniqueID>101088682</NlmUniqueID><ISSNLinking>1472-6947</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="Y">Registries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006113" MajorTopicYN="N" Type="Geographic">United Kingdom</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D036301" MajorTopicYN="Y">Qualitative Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Chronic conditions</Keyword><Keyword MajorTopicYN="N">Disease registry</Keyword><Keyword MajorTopicYN="N">Health research data and infrastructure</Keyword><Keyword MajorTopicYN="N">Long COVID-19</Keyword><Keyword MajorTopicYN="N">Patient registry</Keyword></KeywordList><CoiStatement>Declarations. Ethical approval and consent to participate: Ethical approval for this study was granted by the Research Ethics Committee at the London School of Hygiene &amp; Tropical Medicine (Ref. 28096). Participation in the study was entirely voluntary and participants were free to withdraw at any time without having to give a reason. We used a two-stage consent process. Potential participants were emailed an information sheet as part of the recruitment process and provided written informed consent for the interviews to be recorded and transcribed verbatim, and for quotations to be used in any publications stemming from the study before taking part in an interview. Verbal consent was also sought at the start of the interview to confirm they were happy for the interview to be recorded and to answer any remaining questions. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>11</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>28</Day><Hour>6</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>28</Day><Hour>6</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>28</Day><Hour>3</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>11</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39604990</ArticleId><ArticleId IdType="doi">10.1186/s12911-024-02775-x</ArticleId><ArticleId IdType="pii">10.1186/s12911-024-02775-x</ArticleId><ArticleId IdType="pmc">PMC11603652</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Boulanger V, Schlemmer M, Rossov S, Seebald A, Gavin P. Establishing patient registries for rare diseases: rationale and challenges. Pharmaceut Med. 2020;34(3):185&#x2013;90. 10.1007/s40290-020-00332-1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7286934</ArticleId><ArticleId IdType="pubmed">32215853</ArticleId></ArticleIdList></Reference><Reference><Citation>Carroll C, Palmer A, Cosby C, Zajicek J. Analysis and validation of a Parkinson&#x2019;s disease register as a recruitment tool for clinical studies. Clin Med (Lond). 2012;12(3):210&#x2013;5. 10.7861/clinmedicine.12-3-210.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4953481</ArticleId><ArticleId IdType="pubmed">22783770</ArticleId></ArticleIdList></Reference><Reference><Citation>Jansen-van der Weide MC, Gaasterland CMW, Roes KCB, Pontes C, Vives R, Sancho A, et al. Rare disease registries: potential applications towards impact on development of new drug treatments. Orphanet J Rare Dis. 2018;13(1):154. 10.1186/s13023-018-0836-0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6126025</ArticleId><ArticleId IdType="pubmed">30185208</ArticleId></ArticleIdList></Reference><Reference><Citation>Pop B, Fetica B, Blaga ML, Trifa AP, Achimas-Cadariu P, Vlad CI, Achimas-Cadariu A. The role of medical registries, potential applications and limitations. Med Pharm Rep. 2019;92(1):7&#x2013;14. 10.15386/cjmed-1015.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6448488</ArticleId><ArticleId IdType="pubmed">30957080</ArticleId></ArticleIdList></Reference><Reference><Citation>Zalatel M, M K. Methodological guidelines and recommendations for efficient and rational governance of patient registries. 2015;online: https://health.ec.europa.eu/system/files/2016-11/patient_registries_guidelines_en_0.pdf. Accessed on 21 Feb 2024.</Citation></Reference><Reference><Citation>National Committee on Vital and Health Statistics. Frequently Asked Questions About Medical and Public Health Registries.online: https://ncvhs.hhs.gov/wp-content/uploads/2022/11/FAQ-on-Public-Health-Registries.pdf. Accessed on 14 Feb 2024.</Citation></Reference><Reference><Citation>Perera G, Soremekun M, Breen G, Stewart R. The psychiatric case register: noble past, challenging present, but exciting future. Br J Psychiatry. 2009;195(3):191&#x2013;3. 10.1192/bjp.bp.109.068452.</Citation><ArticleIdList><ArticleId IdType="pubmed">19721105</ArticleId></ArticleIdList></Reference><Reference><Citation>Rankin J, Best K. Disease registers in England. Paediatr Child Health. 2014;24(8):337&#x2013;42. 10.1016/j.paed.2014.02.002.</Citation></Reference><Reference><Citation>Bevan Commission. Establishing a Long COVID Registry for Wales. 2021</Citation></Reference><Reference><Citation>Davies F, Finlay I, Howson H, Rich N. Recommendations for a voluntary Long COVID Registry. J R Soc Med. 2022;115(8):322&#x2013;4. 10.1177/01410768221114964.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9340093</ArticleId><ArticleId IdType="pubmed">35882253</ArticleId></ArticleIdList></Reference><Reference><Citation>House of Representatives Standing Committee on Health ACaS, ,. Sick and tired: Casting a long shadow. Inquiry into Long COVID and Repeated COVID Infections. Parliament of Australia: Canberra. 2023</Citation></Reference><Reference><Citation>University of Auckland. Webpage "Researchers launch long-Covid registry" https://www.auckland.ac.nz/en/news/2023/07/12/researchers-launch-long-covid-registry.html. Accessed on 30 May 2024. 2023.</Citation></Reference><Reference><Citation>NHS England. Long COVID: the NHS plan for 2021/22. 2021;online: https://www.england.nhs.uk/coronavirus/wp-content/uploads/sites/52/2021/06/C1312-long-covid-plan-june-2021.pdf. Accessed on 19 Dec 2023.</Citation></Reference><Reference><Citation>Levin A, Malbeuf M, Hoens AM, Carlsten C, Ryerson CJ, Cau A, et al. Creating a provincial post COVID-19 interdisciplinary clinical care network as a learning health system during the pandemic: Integrating clinical care and research. Learning Health Syst. 2023;7(1):e10316. 10.1002/lrh2.10316.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9348470</ArticleId><ArticleId IdType="pubmed">35942206</ArticleId></ArticleIdList></Reference><Reference><Citation>Naik H, Malbeuf M, Shao S, Wong AW, Tran KC, Russell JA, et al. A Learning Health System for Long Covid Care and Research in British Columbia. NEJM Catalyst. 2023;4(9):CAT.23.0120. 10.1056/CAT.23.0120.</Citation></Reference><Reference><Citation>Pope C, Ziebland S, Mays N. Analysing qualitative data. In: Pope C, Mays N, editors. Qualitative research in health care. Hoboken, Chichester &amp; Oxford: Wiley Online Library; 2020. p. 111&#x2013;133. 10.1002/9781119410867.</Citation></Reference><Reference><Citation>Green J, Thorogood N. Part III: Managing and Analysing Data. In: Green J, Thorogood N, editors. Qualitative methods for health research. 4. Los Angeles, London, New Dehli, Singapore, Washing DC &amp; Melbourne: SAGE; 2018. p. 1&#x2013;440.</Citation></Reference><Reference><Citation>IBD Registry. Webpage "IBD Registry Ltd announces closure amidst NHS data landscape changes" https://ibdregistry.org.uk/2024/01/ibd-registry-announces-closure/. Accessed on 30 May 2024. 2024.</Citation></Reference><Reference><Citation>IBD Registry. Webpage "The Royal College of Physicians to Act as Interim Steward for Safeguarding the IBD Registry Data" https://ibdregistry.org.uk/2024/02/the-royal-college-of-physicians-to-act-as-interim-steward-for-safeguarding-the-ibd-registry-data/. Accessed on 24 May 2024. 2024.</Citation></Reference><Reference><Citation>IBD Registry. Webpage "FAQs about closure" https://ibdregistry.org.uk/closure-faqs/. Accessed on 30 May 2024. 2024.</Citation></Reference><Reference><Citation>The University of Manchester. Webpage "BSRBR-RA study" https://bsrbr.org/. Accessed on 30 May 2024.</Citation></Reference><Reference><Citation>Shenker N, Goebel A, Rockett M, Batchelor J, Jones GT, Parker R, et al. Establishing the characteristics for patients with chronic Complex Regional Pain Syndrome: the value of the CRPS-UK Registry. Br J Pain. 2015;9(2):122&#x2013;8. 10.1177/2049463714541423.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4616964</ArticleId><ArticleId IdType="pubmed">26516567</ArticleId></ArticleIdList></Reference><Reference><Citation>IBD Registry. Webpage "About" https://ibdregistry.org.uk/. Accessed on 30 May 2024.</Citation></Reference><Reference><Citation>University of Liverpool. Webpage "UK JSLE Study Group" https://www.liverpool.ac.uk/life-course-and-medical-sciences/research/groups/ukjsle/. Accessed on 30 May 2024.</Citation></Reference><Reference><Citation>MS Register. Webpage "Overview" https://ukmsregister.org/AboutUs.</Citation></Reference><Reference><Citation>UK Kidney Association. Webpage "UK Renal Registry" https://ukkidney.org/about-us/who-we-are/uk-renal-registry. Accessed on 30 May 2024.</Citation></Reference><Reference><Citation>British Society for Rheumatology. Webpage "ePROMs" https://www.rheumatology.org.uk/improving-care/quality-improvement/eproms. Accessed on 30 May 2024.</Citation></Reference><Reference><Citation>UK Kidney Association. Webpage "UKRDC" https://ukkidney.org/audit-research/data-permissions/ukrdc. Accessed on 30 May 2024.</Citation></Reference><Reference><Citation>UK Kidney Association. Webpage "Data &amp; permissions" https://ukkidney.org/audit-research/data-permissions. Accessed on 30 May 2024.</Citation></Reference><Reference><Citation>NHS England. A06/S/e Assessment And Preparation For Renal Replacement Therapy (including establishing dialysis access). 2015;online: https://www.england.nhs.uk/commissioning/wp-content/uploads/sites/12/2015/01/a06-spec-renal-asses-ad.pdf. Accessed on 19 Dec 2023.</Citation></Reference><Reference><Citation>NHS Digital. Webpage "Understanding the national data opt-out" https://digital.nhs.uk/services/national-data-opt-out/understanding-the-national-data-opt-out. Accessed on 30 May 2024.</Citation></Reference><Reference><Citation>IBD Registry. Website "Joining the IBD Registry" https://ibdregistry.org.uk/information-for-patients/. Accessed on 30 May 2024.</Citation></Reference><Reference><Citation>MS Register. Webpage "Where Does Our Data Come From?" https://ukmsregister.org/Research/OurData. Accessed on 30 May 2024.</Citation></Reference><Reference><Citation>SeRP UK. Webpage "SeRP UK" https://serp.ac.uk/serp-uk/. Accessed on 30 May 2024.</Citation></Reference><Reference><Citation>SAIL Databank. Webpage "Home page". https://saildatabank.com/. Accessed on 30 May 2024.</Citation></Reference><Reference><Citation>British Society for Rheumatology Biologics Register - Rheumatoid Arthritis. Research Governance: BSRBR-RA Stakeholder Responsibilities 2018;online: https://www.bsrbr.org/media/mhs/bmh-faculty/bsrbr-ra/sitefiledocuments/section2-regulatoryandotheressentialdocuments/otherdocumentation/1.-BSRBR-RA-Stakeholder-Responsibilities-v1.0_05122018.pdf. Accessed on 30 May 2024.</Citation></Reference><Reference><Citation>UK Kidney Association. Webpage "UKRR CKD clinical dataset - submission" https://ukkidney.org/audit-research/data-permissions/data-submission/ukrr-ckd-clinical-dataset-submission. Accessed on 30 May 2024.</Citation></Reference><Reference><Citation>UK Kidney Association. Webpage "Patients Know Best" https://ukkidney.org/about-us/who-we-are/patients-know-best.</Citation></Reference><Reference><Citation>Zhang J, Morley J, Gallifant J, Oddy C, Teo JT, Ashrafian H, et al. Mapping and evaluating national data flows: transparency, privacy, and guiding infrastructural transformation. Lancet Digit Health. 2023;5(10):e737&#x2013;48. 10.1016/s2589-7500(23)00157-7.</Citation><ArticleIdList><ArticleId IdType="pubmed">37775190</ArticleId></ArticleIdList></Reference><Reference><Citation>Ford T, Mansfield KL, Markham S, McManus S, John A, O&#x2019;Reilly D, et al. The challenges and opportunities of mental health data sharing in the UK. Lancet Digit Health. 2021;3(6):e333&#x2013;6. 10.1016/s2589-7500(21)00078-9.</Citation><ArticleIdList><ArticleId IdType="pubmed">34044999</ArticleId></ArticleIdList></Reference><Reference><Citation>Keith J, Grimm F, Steventon A. How better use of data can help address key challenges facing the NHS. The Health Foundation. 2022;online: https://www.health.org.uk/publications/long-reads/how-better-use-of-data-can-help-address-key-challenges-facing-the-nhs. Accessed on 30 May 2024.</Citation></Reference><Reference><Citation>Office for Statistics Regulation. Joining Up Data for Better Statistics. 2018;online: https://osr.statisticsauthority.gov.uk/publication/joining-up-data/. Accessed on 30 May 2024.</Citation></Reference><Reference><Citation>Taylor JA, Crowe S, Pujol FE, Franklin RC, Feltbower RG, Norman LJ, et al. The road to hell is paved with good intentions: the experience of applying for national data for linkage and suggestions for improvement. BMJ Open. 2021;11(8):e047575. 10.1136/bmjopen-2020-047575.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8378388</ArticleId><ArticleId IdType="pubmed">34413101</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldacre B, Morley J. Better, Broader, Safer: Using health data for research and analysis. A review commissioned by the Secretary of State for Health and Social Care. Department of Health and Social Care. 2022.&#xa0;https://www.gov.uk/government/publications/better-broader-safer-using-healthdata-for-research-and-analysis/better-broader-safer-using-health-data-for-research-and-analysis.</Citation></Reference><Reference><Citation>Department of Health &amp; Social Care. Data saves lives: reshaping health and social care with data. 2022. online: https://www.gov.uk/government/publications/data-saves-lives-reshaping-health-and-social-care-with-data/data-saves-lives-reshaping-health-and-social-care-with-data. Accessed 25 Nov 2024.</Citation></Reference><Reference><Citation>HDRUK. Webpage "The Sudlow Review" https://www.hdruk.ac.uk/helping-with-health-data/the-sudlow-review/. Accessed on 30 May 2024.</Citation></Reference><Reference><Citation>NHS England. Webpage "Accessing data for research and analysis" https://transform.england.nhs.uk/key-tools-and-info/data-saves-lives/secure-data-environments/accessing-data-for-research-and-analysis/. Accessed on 30 May 2024.</Citation></Reference><Reference><Citation>NHS England. Webpage "The NHS England Secure Data Environment" https://digital.nhs.uk/services/secure-data-environment-service. Accessed on 30 May 2024.</Citation></Reference><Reference><Citation>Blumenthal S. Improving interoperability between registries and EHRs. AMIA Jt Summits Transl Sci Proc. 2018;2017:20&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5961768</ArticleId><ArticleId IdType="pubmed">29888033</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferris TG. Unit cost and hope: increased NHS resilience through tech-enabled transformation. Future Healthc J. 2024;11(1):100021. 10.1016/j.fhj.2024.100021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11025046</ArticleId><ArticleId IdType="pubmed">38646039</ArticleId></ArticleIdList></Reference><Reference><Citation>Deeny SR, Steventon A. Making sense of the shadows: priorities for creating a learning healthcare system based on routinely collected data. BMJ Qual Saf. 2015;24(8):505&#x2013;15. 10.1136/bmjqs-2015-004278.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4515981</ArticleId><ArticleId IdType="pubmed">26065466</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen I, Welch CA, Nazareth I, Walters K, Marston L, Morris RW, et al. Health indicator recording in UK primary care electronic health records: key implications for handling missing data. Clin Epidemiol. 2019;11:157&#x2013;67. 10.2147/clep.S191437.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6377050</ArticleId><ArticleId IdType="pubmed">30809103</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Heide I, Francke AL, D&#xf6;pp C, Heins M, van Hout HPJ, Verheij RA, Joling KJ. Lessons learned from the development of a national registry on dementia care and support based on linked national health and administrative data. Learning Health Syst. 2024;8(2):e10392. 10.1002/lrh2.10392.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11019384</ArticleId><ArticleId IdType="pubmed">38633020</ArticleId></ArticleIdList></Reference><Reference><Citation>HM Government. Webpage "Guidance. National Cancer Registration and Analysis Service (NCRAS)" https://www.gov.uk/guidance/national-cancer-registration-and-analysis-service-ncras. 2020.</Citation></Reference><Reference><Citation>Carter P, Laurie GT, Dixon-Woods M. The social licence for research: why care.data ran into trouble. J Med Ethics. 2015;41(5):404&#x2013;9. 10.1136/medethics-2014-102374.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4431337</ArticleId><ArticleId IdType="pubmed">25617016</ArticleId></ArticleIdList></Reference><Reference><Citation>Ford E, Kazempour Y, Cooper MJF, Katikireddi SV, Boyd A. Media content analysis of general practitioners&#x2019; reactions to care.data expressed in the media: what lessons can be learned for future NHS data-sharing initiatives? BMJ Open. 2020;10(9):e038006. 10.1136/bmjopen-2020-038006.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7485233</ArticleId><ArticleId IdType="pubmed">32912990</ArticleId></ArticleIdList></Reference><Reference><Citation>Hays R, Daker-White G. The care.data consensus? A qualitative analysis of opinions expressed on Twitter. BMC Public Health. 2015;15:838. 10.1186/s12889-015-2180-9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4556193</ArticleId><ArticleId IdType="pubmed">26329489</ArticleId></ArticleIdList></Reference><Reference><Citation>Medical Protection. Webpage "MPS surveys of GPs and public reveal lack of information around care data" https://www.medicalprotection.org/uk/articles/mps-surveys-of-gps-and-public-reveal-lack-of-information-around-care-data. 2014.</Citation></Reference><Reference><Citation>Presser L, Hruskova M, Rowbottom H, Kancir J. Care.data and access to UK health records: patient privacy and public trust. Technol Sci. 2015;2015081103. https://techscience.org/a/2015081103/.</Citation></Reference><Reference><Citation>Cystic Fibrosis Trust. Working with industry to make medicines safer. 2018;online: https://www.cysticfibrosis.org.uk/sites/default/files/2020-11/CC32%20%20Working%20with%20Pharmas%20A4%20v4.pdf. Accessed on 30 May 2024.</Citation></Reference><Reference><Citation>Bilton D, Caine N, Cunningham S, Simmonds NJ, Cosgriff R, Carr SB. Use of a rare disease patient registry in long-term post-authorisation drug studies: a model for collaboration with industry. Lancet Respir Med. 2018;6(7):495&#x2013;6. 10.1016/s2213-2600(18)30192-9.</Citation><ArticleIdList><ArticleId IdType="pubmed">29735358</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Research. Webpage "Services to support study delivery" https://www.nihr.ac.uk/researchers/i-need-help-to-deliver-my-research/services-to-support-study-delivery.htm#two. Accessed on 30 May 2024.</Citation></Reference><Reference><Citation>Viviani L, Zolin A, Mehta A, Olesen HV. The European cystic fibrosis society patient registry: valuable lessons learned on how to sustain a disease registry. Orphanet J Rare Dis. 2014;9:81. 10.1186/1750-1172-9-81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4066270</ArticleId><ArticleId IdType="pubmed">24908055</ArticleId></ArticleIdList></Reference><Reference><Citation>Gliklich R, Dreyer N, Leavy M. Chapter 5. Use of patient-reported outcomes in registries. In: Gliklich RE, Dreyer NA, Leavy MB, editors. Registries for Evaluating Patient Outcomes: A User's Guide [Internet]. 3rd ed. Rockville: Agency for Healthcare Research and Quality (US); 2014</Citation></Reference><Reference><Citation>Nelson EC, Dixon-Woods M, Batalden PB, Homa K, Citters ADV, Morgan TS, et al. Patient focused registries can improve health, care, and science. BMJ. 2016;354:i3319. 10.1136/bmj.i3319.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5367618</ArticleId><ArticleId IdType="pubmed">27370543</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson T, Kollnig K, Dewitte P. Towards responsible, lawful and ethical data processing: Patient data in the UK. Internet Policy Rev. 2022;11(1). 10.14763/2022.1.1638.</Citation></Reference><Reference><Citation>British Academy, The Royal Society. Data management and use: Governance in the 21st century. A joint report by the British Academy and the Royal Society. 2017.&#xa0;https://royalsociety.org/-/media/policy/projects/data-governance/data-managementgovernance.pdf.</Citation></Reference><Reference><Citation>Wiertz S. How to design consent for health data research? An analysis of arguments of solidarity. Public Health Ethics. 2023;16(3):261&#x2013;70. 10.1093/phe/phad025.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10849178</ArticleId><ArticleId IdType="pubmed">38333768</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinsbekk KS, K&#xe5;re Myskja B, Solberg B. Broad consent versus dynamic consent in biobank research: is passive participation an ethical problem? Eur J Hum Genet. 2013;21(9):897&#x2013;902. 10.1038/ejhg.2012.282.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3746258</ArticleId><ArticleId IdType="pubmed">23299918</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoekl&#xe9; H-C, Hulier-Ammar E, Herv&#xe9; C. Data Medicine: &#x2018;Broad&#x2019; or &#x2018;Dynamic&#x2019; Consent? Public Health Ethics. 2022;15(2):181&#x2013;5. 10.1093/phe/phac014.</Citation></Reference><Reference><Citation>Wiertz S, Boldt J. Evaluating models of consent in changing health research environments. Med Health Care Philos. 2022;25(2):269&#x2013;80. 10.1007/s11019-022-10074-3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9135890</ArticleId><ArticleId IdType="pubmed">35286521</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>